News

Emmes today announced that Lynn Lewis has joined the company as chief business officer, a newly created position. Her overall focus is to build deeper relationships with existing clients and to develop new business opportunities, particularly among biotech and pharmaceutical companies.

Emmes today announced the award of eight new task order contract awards associated with the Helping to End Addiction Long-term℠ Initiative, known as the NIH HEAL Initiative℠. The total value for the eight contracts is more than $9 million. The contract awards’ duration ranges from one to five years.

Emmes today announced that it was ranked as one of the 100 largest private companies in the Washington metropolitan area. The ranking is compiled annually by the Washington Business Journal. The company was ranked as the 83rd largest private company this year. Its most recently reported revenues were more than $114 million, and about 600 of the company’s 725 employees work in the Washington area.

Emmes today announced that it has received a Workplace Excellence Seal of Approval from Alliance for Workplace Excellence (AWE). This is the fifth consecutive year the company has received the AWE Workplace Excellence award.

New Medical Device Guidance on Article 15 of the MDR and IVDR regarding person responsible for regulatory compliance

Emmes today announced that it provided the data management support for a study, funded by the National Institutes of Health (NIH) and approved by the Food and Drug Administration (FDA), to safely use Acyclovir to treat infants infected with the Herpes Simplex Virus. Acyclovir, known by the brand name Zovirax, now includes recommended usage and dosage for newborns and infants up to three months of age on its label.

Congrats to the Neox team and their work, which was recognized in a recent publication

Emmes today announced that Behrman Capital, a leading private equity firm, has made a significant investment in the company. The capital will allow Emmes, one of the Washington area’s top 100 largest private companies, to expand and strengthen its service offerings and international presence.

The Emmes Corporation today announced that it was named one of the largest women-owned businesses in the Washington metropolitan area by the Washington Business Journal. Emmes was ranked the sixth largest women-owned business in the Washington region, up from number seven last year. Last month, Emmes was named as one of the top 100 largest private companies in the area. Emmes ranked 83rd, up from 95th the previous year, in the Washington Business Journal’s annual list.

This is to inform you about how your personal data is processed by NEOX s.r.o. These principles describe how your personal data is obtained and processed. At the same time, please be assured that any and all personal data processed is considered as strictly confidential by NEOX s.r.o. and is handled in compliance with applicable legal regulations. Personal data is under the control and protection of NEOX s.r.o., and NEOX s.r.o. has established mechanisms to ensure an adequate protection of processed personal data against its misuse.

The Emmes Corporation today announced that scientists and health professionals from the company, LDS Hospital in Salt Lake City, Utah, Lovelace Biomedical Environmental Research Institute in Albuquerque, New Mexico, and the U.S. Army Medical and Materiel Development Activity at Fort Detrick, Maryland, have completed a multi-year clinical trial testing hyperbaric oxygen as an intervention for U.S. military service members who have suffered mild traumatic brain injuries with persistent symptoms.

The Emmes Corporation today announced the creation of an internship program in which the company will offer one fellow from Egypt’s Children Cancer Hospital an internship to gain training and experience in clinical research. Under the new program, one fellow will be selected each year to travel to Emmes’ headquarters in Rockville, Maryland, to work with its clinical research experts. The duration of each internship will be determined on a case-by-case basis.